86 021-5169 5932 

Garrett Leight California Optical

Partners Products
Hots / Products
发布时间: 2023 - 06 - 13
As one of the world's leading specialty chemical companies, Clariant contributes to value creation with innovative and sustainable solutions for customers from many industries.Our portfolio is designed to meet very specific needs with as much precision as possible. At the same time, our research and development is focused on addressing the key trends of our time. These include energy efficiency, renewable raw materials, emission-free mobility, and conserving finite resources. High performance excipients leveraged on high-quality standardsPharmaceutical Excipients for effective solubilization, bioavailability enhancement, controlled release, target delivery, stabilization, continuous manufacturing, preservation and viscosity enhancement.With a positive and progressive track-record ...
发布时间: 2023 - 06 - 13
A&C is a global GMP manufacturer of excipients, buffers, process solutions and a select number of active pharmaceutical ingredients (APIs). We have been servicing the life science industry since 1966, and expanded our footprint globally through the years. We currently have offices and GMP production facilities in North America and Europe.A&C works with a variety of products at our three GMP manufacturing facilities. We began with custom manufacturing of high purity solutions in 1966. The applications of our products include injectable, dermal, nasal, ophthalmic applications, preservatives, pH adjusters, cleaning solutions, solvents, flavours and aromatic compounds, lubricants, binders, antioxidants, process solutions and buffers. We offer GMP customized services for all our excipie...
发布时间: 2023 - 06 - 13
Antares Vitamin E TPGS has a record of safety based on decades of use in humans and animals and on reported toxicology studies. It is safe for transportation, storage and handling. Vitamin E TPGS has a self-affirmed GRAS (Generally Recognized As Safe) status when used as an oral dietary supplement of vitamin E.Antares Vitamin E TPGS solubilizes, emulsifies, and enhances the absorption of difficult to absorb lipophilic APIs in a wide range of pharmaceutical dosage forms and drug delivery systems. This ensures your drug will work as though it has high potency API.Advantages of Antares Vitamin E TPGS as an Emulsifying Agent in Pharmaceuticals:• Available in NF grade• Versatile, functional excipient with proven success in oral (solids and liquids), topical, ocular, mucosal and parent...
Contact us
Tel: 86-21-5169 5932
Email: info@ronpharm.com
Add: 11F Central Plaza, Huaan Road, Kunshan, China


上市日期: 2019-04-25

Country of Origin: Belgium

Citric Acid Anhydrous

Citric Acid Monohydrate

Trisodium Citrate Dihydrate

Monosodium Citrate Anhydrous

Citrique Belge Tienen is a cost competitive, high quality and service oriented company focusing on customer needs and strongly considering ecological and environmental aspects in all its decisions. Safety and employee engagement and commitment are our basic pillars. Each new day enthusiast and competent staff at Citrique Belge are professionally delivering citric acid and/or associated co-products to our customers in line with their order schemes and planning.

In doing so, we use state-of-the-art methods and techniques to stay ahead in the very competitive world market and to remain the leader in quality and cost. We further aim to achieve a wholly safe production and work environment, the lowest possible burden on the ecology and a good relationship with our neighbours.

To Citrique Belge this means that we want to add value each day innovatively and progressively.

For more information, please visit:  https://www.citribel.com/

Tienen, 20 January 2020

INITIATION OF AN EXPIRY REVIEW of the anti-dumping measures applicable to imports of citric acid originating in the People’s Republic of China

With the publication 2020/C 18/03 in the Official Journal of the European Union, dated January 20, 2020, the EU commission has announced the initiation of an expiry review of the current existing anti-dumping measures to imports of citric acid originating in the People’s Republic of China. The request for review was introduced by the European citric acid manufacturers in October 21, 2019.

The request is based on the grounds that the expiry of measures would likely result in continuation of dumping and reoccurrence of injury to the Union industry.

The product subject to this review is citric acid and trisodium citrate under the CN codes 2918 1400 and 2918 1500. The measures currently in force are a definitive anti-dumping duty imposed by Commission Regulation (EU) 2015/82.

The investigation starts today and shall normally be concluded within 12 months and in any event not later than 15 months from the date of publication of this Notice. During this time the current measures will remain in place.



In 1916 Alphonse Cappuyns began research at the University of Louvain into producing citric acid by fermenting sugar. Entrepreneurs perceived this development as a business opportunity for the local sugar industry. Given the first, very promising, results “Les Produits Organiques de Tirlemont” (P.O.T.) was established in 1919.

The first fermentation chamber was filled with 1,300 kg of sugar and seeded with citromyces. Unfortunately, the first yields were extremely low. Even after some improvements, this new fermentation process could not compete with the lemon refining industry, based mainly in Sicily. In October 1925, P.O.T. had to cease its production activities.

Despite this setback, Alphonse Cappuyns continued to believe in the eventual success of his approach and began his research once again, this time using a new micro-organism: Aspergillus niger.

With this second attempt, he achieved a production yield that justified industrial operations. In 1929, a Belgian - Italian joint venture was established : La Citrique Belge. The Belgian know-how in fermentation was combined with the Italian know-how in refining citric acid.

In 1947, fermentation of molasses - a by-product of the local sugar refinery - was introduced as a replacement of the fermentation of the much more expensive pure sugar. At the same time, the Italian joint venture partners left the company and La Citrique Belge became 100% Belgian.

In 1977, Citrique Belge became a member of the Swiss pharmaceutical group F. Hoffmann La Roche. Citric acid was a good addition to the product portfolio of the leading supplier of vitamins to the food industry. The company expanded production to over 112.000 ton/year and started a joint-venture with a Chinese plant in Wuxi.

In 2003, Citrique Belge was sold to DSM. After some improvements in the production organization and an increase of the capital, the capacity rose to 120.000 ton and the Chinese plant was closed.

In October 2010, Citrique Belge became a member of the ADCURAM Group.  Important investments were done not only in refinery but also in fermentation and waste water treatment. 

End of 2016, Citrique Belge was acquired by an international group of private investors.  These private investors all share a common long term vision of creating profitable growth in specific industrial companies via a quality-driven operational management, strategic orientation and a close, enduring relationship with its B2B customers. 

Being a stand-alone investment, Citrique Belge now enjoys the autonomy to continue to invest in fermentation, downstream processing, quality, product development, sales and logistics to remain a reliable supplier of citric acid and its derivative products - providing excellent service, technical expertise and quality products - in the many years to come. 

After several important reorganizations and major investments to modernize and optimize the production processes, Citrique Belge is, today one of the largest and most efficient citric acid producers in the world.

In 1916, Mr Alphonse Cappuyns lived with his young wife near the pharmacy of his parents in law. Inspired by the lack of available citric acid for the pharmacy due to the first World War, Mr Cappuyns began researching the possibility of producing citric acid without lemons. His academic background as a fermentation specialist encouraged him to try and implement a German theory from the 19th century, which in essence claimed that citric acid could be produced by fermenting sugar. His first findings were negative: the theory was only theory and could not be turned into reality. But persevering as he was, he kept trying to find other organisms and experimented with a wide variety of process circumstances, which slowly led to first results.
Citribel_5_Purpose_history 1916
Based on these first results, “Les Produits Organiques de Tirlemont” (P.O.T.) was founded in 1919. A small first fermentation chamber was filled and seeded with spores. Unfortunately, the citric acid yields were lower than expected, but many improvements were made in the next few years.
Despite these improvements, the new fermentation process could still not compete with the Italian lemon refining industry, and in 1925 P.O.T. was forced to halt its production activities. Mr Alphonse Cappuyns however continued to believe in the success of his approach and pursued his research. Barely three months later, using yet another micro-organism, he achieved a production yield that justified industrial operations and P.O.T. restarted production.
In 1929, Belgian know-how in fermentation was combined with Italian know-how in refining citric acid. A Belgian-Italian joint venture was established: “La Citrique Belge”. Today, the combination of both areas of expertise still forms the backbone of our high-quality products and applications.
Almost 20 years later, in 1947, the Italian partners left the company and Citrique Belge became 100% Belgian. The Belgians continued to improve the fermentation process. In 1948, the process expertise was sufficiently evolved to replace sugar as a raw material with less expensive sugar molasses. Hence, Citrique Belge became a circular company in its core, by upcycling a sidestream from another industry. During the following decades, fermentation yields, and production volumes slowly continued to increase.
Between 1977 and 2016, under the leadership and expertise of various subsequent owners, such as F. Hoffman La Roche, DSM and Adcuram, various capital increases and strong investments in production capacity were made. From an early stage, wastewater treatment was considered important and various investments were made to improve Citrique Belge’s wastewater cycle. Also, the high volumes and wide variety of valuable co-products became more and more important.
In 2016, Citrique Belge was acquired by a group of private Belgian investors and became an independent company again. These private investors all shared the vision of creating a long-term profitable company, with the balanced interests of all stakeholders in mind, equally focusing on citric acid and all the co-products.
With circularity and sustainability at its historical core, Citrique Belge develops into Citribel, an industrial producer and innovative expert in various bioprocesses, resulting in a wide variety of natural products for high-value applications.

Related Products / Case 更多>>
2023 - 06 - 13
2023 - 06 - 13
2023 - 06 - 13
      RonPharm Corp.
Copyright ©2013 - 2023 RonPharm Corp.
Serviced by RonCloud
Serviced by RonCloud
11F Central Plaza, Huaan Road, Kunshan, Jiangsu, China
Tel : 86 021-5169 5932
            Fax : 86 021-5168 5270